This content is restricted.
Brief
Summary:
Based on the provided text, here is a summary of the part:
The Regulation (EC) No 469/2009 of the European Parliament and of the Council aims to provide supplementary protection certificates (SPCs) for medicinal products. SPCs grant patent holders a longer period of exclusive marketing rights in the European Community. The regulation outlines the purpose, scope, and duration of the protection and the conditions for granting the certificate. It also includes recitals that provide additional context for the provisions.
Highlights content goes here...
This content is restricted.
RADA.AI
Hello! I'm RADA.AI - Regulatory Analysis and Decision Assistance. Your Intelligent guide for compliance and decision-making. How can i assist you today?
Suggested